Edition:
United States

China NT Pharma Group Co Ltd (1011.HK)

1011.HK on Hong Kong Stock

1.86HKD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
HK$1.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,815,451
52-wk High
HK$2.22
52-wk Low
HK$1.27

Latest Key Developments (Source: Significant Developments)

China NT Pharma Group Co says HY profit attributable to equity shareholders up 61.1 pct
Monday, 21 Aug 2017 09:56am EDT 

Aug 21 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::HY profit attributable to equity shareholders of company increased by 61.1% from RMB50.1 million to RMB80.7 million.HY overall revenue of group up 44.9 percent to RMB559.1 million.  Full Article

China NT Pharma enters deal to issue 325 mln shares at HK$1.83 per share
Wednesday, 19 Apr 2017 08:51am EDT 

April 19 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>:Company entered into placing agreement.Co agreed to issue aggregate of 325 million convertible preference shares at a price of HK$1.83 per convertible preference shares.  Full Article

China NT Pharma says FY net profit RMB 116.2 mln
Tuesday, 21 Mar 2017 06:30pm EDT 

China Nt Pharma Group Co Ltd <1011.HK>: Board recommended a final dividend of hk2.5 cents per share . Group reported a net profit of rmb116.2 million for year ended 31 december 2016, as compared with a net profit of rmb87.7 million .Overall revenue of the group for the year ended 31 december 2016 increased by rmb67.4 million or 7.9% to rmb915.1 million.  Full Article

China Nt Pharma obtains certification from China Food and Drug Administration
Thursday, 2 Mar 2017 11:16pm EST 

China Nt Pharma Group Co Ltd <1011.HK>: Jiangsu NT Biopharma successfully obtained new good manufacturing practices certification from China Food and Drug Administration .Estimated that production line can commence production of "Xi Di Ke" in March and sales will officially commence in April.  Full Article

China NT Pharma says co entered into asset purchase agreement with Novartis<1011.HK>
Wednesday, 18 May 2016 10:39am EDT 

China NT Pharma Group Co Ltd <1011.HK>: NT Pharma (as purchaser) entered into asset purchase agreement with Novartis . Purchase price would be in the aggregate sum of US$145 million . Co has made an application for the resumption of trading in the shares of co with effect from 9:00 a.m. on Thursday, 19 May 2016 .  Full Article

China NT Pharma says trading halted pending release of announcement regarding signed agreements of acquisition<1011.HK>
Wednesday, 18 May 2016 12:39am EDT 

China NT Pharma Group Co Ltd <1011.HK>: Trading halt . Seeks trading halt pending release of announcement in relation to signed agreements of acquisition of pharmaceutical assets .  Full Article

China NT Pharma Group Co Ltd says in discussions regarding acquisition of pharmaceutical assets
Tuesday, 5 Apr 2016 12:03am EDT 

China NT Pharma Group Co Ltd:Voluntary announcement potential acquisition.Company is in discussions with an independent third party regarding the potential acquisition of pharmaceutical assets.Company has not entered into any definitive agreement in relation to the potential acquisition.As at date of announcement, no material terms concerning potential acquisition have been agreed.  Full Article

BRIEF-China Nt Pharma Group Co Says Co To Cease Libod Sales & Promotion From Dec. 31, 2017

* ENTERS DEAL TO TERMINATE SALES & PROMOTION DEAL, CO TO CEASE LIBOD SALES & PROMOTION FROM DEC. 31, 2017 Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)